etoposide

Generic: etoposide

Labeler: bluepoint laboratories
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name etoposide
Generic Name etoposide
Labeler bluepoint laboratories
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

etoposide 20 mg/mL

Manufacturer
BluePoint Laboratories

Identifiers & Regulatory

Product NDC 68001-265
Product ID 68001-265_30d6f51a-8099-4ff9-9be6-fb0559c88e42
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA074513
Listing Expiration 2026-12-31
Marketing Start 2013-11-14

Pharmacologic Class

Established (EPC)
topoisomerase inhibitor [epc]
Mechanism of Action
topoisomerase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68001265
Hyphenated Format 68001-265

Supplemental Identifiers

RxCUI
310248
UPC
0368001265225
UNII
6PLQ3CP4P3
NUI
N0000175609 N0000000176

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name etoposide (source: ndc)
Generic Name etoposide (source: ndc)
Application Number ANDA074513 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 20 mg/mL
source: ndc
Packaging
  • 1 VIAL, MULTI-DOSE in 1 BOX (68001-265-25) / 5 mL in 1 VIAL, MULTI-DOSE (68001-265-22)
  • 1 VIAL, MULTI-DOSE in 1 BOX (68001-265-26) / 25 mL in 1 VIAL, MULTI-DOSE (68001-265-23)
  • 1 VIAL, MULTI-DOSE in 1 BOX (68001-265-27) / 50 mL in 1 VIAL, MULTI-DOSE (68001-265-24)
source: ndc

Packages (3)

68001-265-25 1 VIAL, MULTI-DOSE in 1 BOX (68001-265-25) / 5 mL in 1 VIAL, MULTI-DOSE (68001-265-22) 68001-265-26 1 VIAL, MULTI-DOSE in 1 BOX (68001-265-26) / 25 mL in 1 VIAL, MULTI-DOSE (68001-265-23) 68001-265-27 1 VIAL, MULTI-DOSE in 1 BOX (68001-265-27) / 50 mL in 1 VIAL, MULTI-DOSE (68001-265-24)

Ingredients (1)

etoposide (20 mg/mL)

Linked Drug Pages (1)

Etoposide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "30d6f51a-8099-4ff9-9be6-fb0559c88e42", "openfda": {"nui": ["N0000175609", "N0000000176"], "upc": ["0368001265225"], "unii": ["6PLQ3CP4P3"], "rxcui": ["310248"], "spl_set_id": ["157d4e0f-806d-4011-9dec-97e2449e507b"], "pharm_class_epc": ["Topoisomerase Inhibitor [EPC]"], "pharm_class_moa": ["Topoisomerase Inhibitors [MoA]"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 BOX (68001-265-25)  / 5 mL in 1 VIAL, MULTI-DOSE (68001-265-22)", "package_ndc": "68001-265-25", "marketing_start_date": "20131114"}, {"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 BOX (68001-265-26)  / 25 mL in 1 VIAL, MULTI-DOSE (68001-265-23)", "package_ndc": "68001-265-26", "marketing_start_date": "20131114"}, {"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 BOX (68001-265-27)  / 50 mL in 1 VIAL, MULTI-DOSE (68001-265-24)", "package_ndc": "68001-265-27", "marketing_start_date": "20131114"}], "brand_name": "Etoposide", "product_id": "68001-265_30d6f51a-8099-4ff9-9be6-fb0559c88e42", "dosage_form": "INJECTION", "pharm_class": ["Topoisomerase Inhibitor [EPC]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "68001-265", "generic_name": "Etoposide", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Etoposide", "active_ingredients": [{"name": "ETOPOSIDE", "strength": "20 mg/mL"}], "application_number": "ANDA074513", "marketing_category": "ANDA", "marketing_start_date": "20131114", "listing_expiration_date": "20261231"}